Back
BioXcel Therapeutics Vs. Apogee Enterprises Industry Stock Comparison
Sell
8
BTAI
BioXcel Therapeutics
Last Price:
1.30
Seasonality Move:
-23.4%
Buy
61
APOG
Apogee Enterprises
Last Price:
63.05
Seasonality Move:
0.92%
Sell
8
BioXcel Therapeutics (BTAI)
is a Sell
Is BioXcel Therapeutics a Buy, Sell or Hold?
- The current BioXcel Therapeutics [BTAI] share price is $1.28. The Score for BTAI is 8, which is 84% below its historic median score of 50, and infers higher risk than normal.
- BTAI is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
61
Apogee Enterprises (APOG)
is a Buy
Is Apogee Enterprises a Buy, Sell or Hold?
- The current Apogee Enterprises [APOG] share price is $63.06. The Score for APOG is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
- APOG is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BTAI Stock Price Chart
What is BioXcel Therapeutics's stock price today?
-
The BioXcel Therapeutics share price today is $1.28
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BTAI is experiencing selling pressure, which indicates risk of future bearish movement.
APOG Stock Price Chart
What is Apogee Enterprises's stock price today?
-
The Apogee Enterprises share price today is $63.06
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APOG is experiencing slight selling pressure.
BTAI Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.2 | Sell |
Relative Strength Index (14 RSI): | 33.21 | Sell |
Chaikin Money Flow: | -1111346 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.24 - 1.72) | Sell |
Bollinger Bands (100): | (1.76 - 3.12) | Sell |
APOG Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.52 | Sell |
Relative Strength Index (14 RSI): | 52.89 | Buy |
Chaikin Money Flow: | -136947 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (60.7 - 64.72) | Buy |
Bollinger Bands (100): | (56.24 - 63.86) | Buy |
BTAI Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.22 | Buy |
20-day SMA: | 1.39 | Sell |
50-day SMA: | 1.94 | Sell |
200-day SMA: | 2.86 | Sell |
8-day EMA: | 1.27 | Buy |
20-day EMA: | 1.42 | Sell |
50-day EMA: | 1.83 | Sell |
200-day EMA: | 4.25 | Sell |
APOG Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 61.18 | Buy |
20-day SMA: | 61.94 | Buy |
50-day SMA: | 63.23 | Sell |
200-day SMA: | 54.21 | Buy |
8-day EMA: | 61.73 | Buy |
20-day EMA: | 62.13 | Buy |
50-day EMA: | 62.04 | Buy |
200-day EMA: | 56.06 | Buy |
BioXcel Therapeutics Earnings Growth & BTAI Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.65 per share, an increase next quarter of $0.18 per share, an increase this year of $3.38 per share, and an increase next year of $0.97 per share.
Apogee Enterprises Earnings Growth & APOG Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.06 per share, an increase this year of $0.67 per share, and an increase next year of $0.11 per share.
BioXcel Therapeutics Technical Analysis
Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Apogee Enterprises Technical Analysis
Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |